Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bochner

Showing results (181-190 of 277) with videos related to

Pageof 28
Sort By:
The Journal of Biological Chemistry|November 26, 2004
Glycan array screening reveals a candidate ligand for Siglec-8Bruce S Bochner, Richard A Alvarez, Padmaja Mehta, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivityJennifer A Regan, Yun Cao, Melanie C Dispenza, et al.
Research Square|April 17, 2023
Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trialRagha V Suresh, Collin Dunnam, Dhananjay Vaidya, et al.
Expert Opinion on Drug Delivery|January 11, 2023
Drug delivery targets and strategies to address mast cell diseasesClayton H Rische, Ariel N Thames, Rebecca A Krier-Burris, et al.
The Journal of Clinical Investigation|June 3, 2020
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxisMelanie C Dispenza, Rebecca A Krier-Burris, Krishan D Chhiba, et al.
The Journal of Clinical Investigation|June 29, 2023
A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxisRagha V Suresh, Collin Dunnam, Dhananjay Vaidya, et al.
Blood|March 21, 1998
In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibodyD MacGlashan, J McKenzie-White, K Chichester, et al.
The Journal of Allergy and Clinical Immunology|March 9, 1999
Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent mannerB S Bochner, C A Bickel, M L Taylor, et al.
Blood|November 1, 1993
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophilsS N Georas, B W McIntyre, M Ebisawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivoS S Saini, D W MacGlashan, S A Sterbinsky, et al.
Pageof 28

Showing results (181-190 of 277) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|November 26, 2004
Glycan array screening reveals a candidate ligand for Siglec-8Bruce S Bochner, Richard A Alvarez, Padmaja Mehta, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivityJennifer A Regan, Yun Cao, Melanie C Dispenza, et al.
Research Square|April 17, 2023
Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trialRagha V Suresh, Collin Dunnam, Dhananjay Vaidya, et al.
Expert Opinion on Drug Delivery|January 11, 2023
Drug delivery targets and strategies to address mast cell diseasesClayton H Rische, Ariel N Thames, Rebecca A Krier-Burris, et al.
The Journal of Clinical Investigation|June 3, 2020
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxisMelanie C Dispenza, Rebecca A Krier-Burris, Krishan D Chhiba, et al.
The Journal of Clinical Investigation|June 29, 2023
A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxisRagha V Suresh, Collin Dunnam, Dhananjay Vaidya, et al.
Blood|March 21, 1998
In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibodyD MacGlashan, J McKenzie-White, K Chichester, et al.
The Journal of Allergy and Clinical Immunology|March 9, 1999
Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent mannerB S Bochner, C A Bickel, M L Taylor, et al.
Blood|November 1, 1993
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophilsS N Georas, B W McIntyre, M Ebisawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivoS S Saini, D W MacGlashan, S A Sterbinsky, et al.
Pageof 28